US Patent 9611214 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors

Patent 9611214 was granted and assigned to Otsuka Pharmaceutical on April, 2017 by the United States Patent and Trademark Office.